Delcath Systems to Present at BTIG Healthcare Conference in February 2024
Delcath Systems (Nasdaq: DCTH), an interventional oncology company specializing in liver cancer treatments, has announced...
Delcath Systems (Nasdaq: DCTH), an interventional oncology company specializing in liver cancer treatments, has announced...
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
The initiative aims to promote awareness, screening and early detection for chronic kidney disease to eliminate barriers and disparities facing...